Clinical trial MO29112
A multi-centre randomized clinical trial of Biomarker-Driven maintenance treatment for first-line metastatic colorectal cancer (MODUL)
Cancers | |
---|---|
Organ | Colon |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | Roche |
EudraCT Identifier | 2014-001017-61 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02291289 |
Inclusion criteria | first line RECIST 1.1 |
Last update |